ADPT
#1503
Adaptive Biotechnologies Corporation - Common Stock
25.2 1 USD
-0.05%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-4.65%
Changement Mensuel
+12.14%
Evolution sur 6 mois
+62.54%
Changement Annuel
+46.06%
Clôture Précédente
26.4 4
Open
25.3 6
Low
25.1 3
High
25.4 6
Volume
1 128
Financials
- Market Capitalization 4.02 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-41.64
ratio cours/chiffre d'affaires
8.9
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1462 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 57.85 USD | -4.38% | -3.29% | +7.15% | +180.01% | 4.24 B USD | ||
| 1497 |  RLAY Relay Therapeutics, Inc. - Common Stock | 18.77 USD | -3.35% | -3.45% | +1.46% | +404.57% | 4.11 B USD | ||
| 1508 |  TNGX Tango Therapeutics, Inc. - Common Stock | 23.36 USD | -7.59% | -2.18% | -12.90% | +241.02% | 3.94 B USD | ||
| 1518 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.78 USD | -6.46% | -10.04% | +78.36% | +268.04% | 3.88 B USD |